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Abstract
Protein design has come of age, but how will it mature? In the 1980s and the 1990s, the primary motiva-
tion for de novo protein design was to test our understanding of the informational aspect of the protein-
folding problem; i.e., how does protein sequence determine protein structure and function? This necessi-
tated minimal and rational design approaches whereby the placement of each residue in a design was
reasoned using chemical principles and/or biochemical knowledge. At that time, though with some notable
exceptions, the use of computers to aid design was not widespread. Over the past two decades, the tables
have turned and computational protein design is firmly established. Here, I illustrate this progress through
a timeline of de novo protein structures that have been solved to atomic resolution and deposited in the
Protein Data Bank. From this, it is clear that the impact of rational and computational design has been
considerable: More-complex and more-sophisticated designs are being targeted with many being
resolved to atomic resolution. Furthermore, our ability to generate and manipulate synthetic proteins
has advanced to a point where they are providing realistic alternatives to natural protein functions for
applications both in vitro and in cells. Also, and increasingly, computational protein design is becoming
accessible to non-specialists. This all begs the questions: Is there still a place for minimal and rational
design approaches? And, what challenges lie ahead for the burgeoning field of de novo protein design
as a whole?
 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CCBY license (http://creativecom-
mons.org/licenses/by/4.0/).Introduction from protein engineering
to protein design
In August 1988 I attended the Protein Society’s
2nd Annual Symposium in San Diego.1 I was a
first-year graduate student, it was my first interna-
tional conference, and it changed my life. Bill
DeGrado spoke about his attempts to design four-
helix bundle proteins using a chemocentricA Brief History of De Novo Protein Design: Minimal, Rational, and
or(s). Published by Elsevier Ltd.This is an opapproach to assemble short amphipathic helices
in water.2,3 I was hooked, and I wanted to design
proteins from then on. The intervening 30+ years
have witnessed considerable changes in both the
approaches to and the successes of this field of
de novo protein design. Indeed, the early minimal
and rational approaches to protein design—which
were pioneered by a small number of research
groups—have been overtaken by computational
protein design, which is now being practiced byComputationalJournal of Molecular Biology, https://doi.org/10.1016/j.jmb.2021.167160
en access article under the CC BY license (http://creativecommons.org/
Journal of Molecular Biology (xxxx) xxx, xxx
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that I pose here: have minimal and rational de novo
protein design served their purpose? Is it time to
move on and fully embrace the power and potential
of computational de novo protein design? And, what
challenges remain for the field? Before I address
these questions, I’d like tomake it clear that this arti-
cle is not intended as an exhaustive review of the de
novo protein design field – that would be challeng-
ing. Rather, it is a more-focussed piece written from
my own perspective. There are several exceptional
recent reviews of protein design, which together
give a thorough overview of the current state-of-
the-art of the field.4–7 Also, I’d like to set the scene
in three ways as follows.
First, I need to make a distinction. Protein design
is different from protein engineering. In the latter,
natural proteins are engineered or redesigned to
understand natural protein functions, to alter these
functions, or to repurpose the natural protein
structures for new functions. The advantage is
that protein structure, stability and dynamics are
defined, even if they are not fully understood. The
basic tenet of protein engineering is that these
features remain largely unperturbed following
mutagenesis. This allows researchers to
target altered or new functions through rational
mutagenesis or by directed evolution.8,9 The impact
of protein engineering over the past four decades
has been astounding, and this was acknowledged
by the award of the 2018 Nobel Prize for Chemistry
to Frances Arnold, George Smith and Greg
Winter.10
That said, and before moving on from protein
engineering, I should note that considerable
progress in this field has been made by protein
designers developing computational tools to guide
mutagenesis studies. David Baker’s Rosetta suite
of computational tools being a prime example11,12;
and an excellent specific example is Sarel Fleish-
man’s PROSS tool and server for improving protein
expression and stability through computationally
selected mutations.13 In addition, improved compu-
tational methods have contributed to advances in
enzyme design. At present, though with some
exceptions,14,15 these have largely been applied to
repurposing natural protein structures. I do not
review this exciting area here, but others who have
pioneered the field—notably, Don Hilvert and Ross
Anderson—have done so.8,16,17 Thus, in these
respects the boundary between protein engineering
and protein design is blurred. Indeed, I recognise
fully that making wholesale changes to natural pro-2
teins to introduce completely new functions—such
as catalysis, small-molecule binding, and protein–
protein interactions—is non-trivial and is considered
protein design by many.
By contrast, in de novo protein design it is
generally accepted that the starting point or
scaffold isn’t a given. Indeed, it is the initial target
for design. Usually, and in the broadest terms, this
is done by choosing a target protein shape or
assembly and then finding a sequence, or
sequences most likely to fold to and stabilise that
target. For the next step of introducing function,
there are two schools of thought in de novo
design18: some advocate generating stably folded
scaffolds first and then embellishing these with
functions; while others argue that the processes of
structural and functional design should be more
integrated–in short, the de novo proteins should
be built around the functional regions.
Second, and before getting too embroiled in the
details of protein design, we need some
boundaries, definitions and illustrations. The
primary objective and indeed the definition of de
novo protein design is simple: what synthetic
sequence(s) can be made to direct the folding and
stabilisation of a target protein structure and
function? As such, protein design is often called
the inverse protein-folding problem.19 Of course,
the reality is that this is far from simple to achieve;
indeed, it has proved extremely challenging to get
to where we are today. In Box 1, I give definitions
for what I consider the three main approaches to
protein design—namely, minimal, rational, which
encompasses consensus, and computational
design—together with some of their pioneers, and
the merits and shortcomings of the different
approaches. I find the definitions useful, and I hope
that they would be generally accepted by the
broader protein-design community. In Figures 1
and 2, which I describe in detail below and refer to
throughout the article, I have attempted to plot a
structural history of the progress made in de novo
protein design using these approaches. This is a
timeline of experimentally determined high-
resolution structures of de novo peptides and pro-
teins. My intention is to illustrate the trajectory and
progress of the field over three decades. My hope
is that it will form the basis for building a structural
database of de novo protein designs. In turn, this
would be a source for viewing, analysing and learn-
ing from de novo protein designs, as has been
achieved using the RCSB PDB and relational data-
bases that have sprung from it over five decades.20
Box 1. Approaches and pioneers.
Minimal protein design6,21 uses straightforward chemi-
cal principles such as patterning of polar (p) and
hydrophobic (h) amino-acid residues to direct the folding
and assembly of secondary structures leveraging the
hydrophobic effect. For instance, in aqueous buffers
. . .hpphppp. . . and . . .hphphp. . . patterns can lead to the
formation and association of amphipathic a helices and
b strands, respectively. The experimental approaches
to this can be step-wise—i.e., through careful biophysi-
cal studies of small numbers of synthetic polypeptides,
as pioneered by DeGrado.
7 Or they can be combinatorial—i.e. via the generation of
libraries of large numbers of protein sequences from syn-
thetic genes built with redundant codons, and then selecting
variants with desired biophysical or functional properties, as
championed by Michael Hecht.22,23 The advantage of these
approaches is that they test straightforward concepts and
principles, and that complexity can be built from the bottom
up. Other early proponents of minimal design include: Jane
and David Richardson24–26; Les Dutton who pioneered the
maquette approach to design functional helical bundles that
incorporate various cofactors27,28; and Bob Hodges who
designed the first de novo coiled-coil peptides.29,30 Sadly,
Bob passed away recently.31 The minimal approach resulted
in the concepts of positive and negative protein design: i.e.,
that even seemingly straightforward design targets such as
the 4-helix bundle can have multiple arrangements; there-
fore, whilst positive design principles are needed to design
towards the target, negative design is also required to direct
away from unwanted alternative states.
Though the boundary is somewhat blurred, rational
protein design3,32 builds on from minimal approaches
by embellishing simple hp patterns with more-specific
sequence-to-structure relationships garnered from bio-
chemical, bioinformatics or empirical studies. The
advantage of speed of turnaround in design-build-test
cycles from minimal design is maintained, but the
robustness of the designs is improved by including bio-
chemical and evolutionary sequence-to-structure data.
One of the first examples to bridge minimal and rational
protein design was Lynne Regan and DeGrado’s single-
chain 4-helix bundle,33 which Regan and Neil Clarke
adapted to introduce a zinc-binding site.34 The rational
approach has worked particularly well for targets such
as multi-a-helix coiled-coil assemblies, where clear
sequence-to-structure relationships to define different
coiled-coil architectures came through the analysis of
natural structures and systematic experiments.35–37
Early exponents here include: TomAlber,38,39 Vince Con-
ticello,40,41 DeGrado,7,42 Hodges,30,43 Peter Kim,44 Vince
Pecoraro,45 andmy own group46–48; and for early b struc-
tures Tanja Kortemme and Luis Serrano.49
I also include consensus protein design in the rational
designcategory.50–52 In thisapproach,multiplealignment
of natural sequences for a target structure are used to
identify the key residues and residue spacings that define
the fold.Theseare thenusedtobuildsyntheticversionsof
thestructure.Adifferencebetweentheconsensusand the
general rational approaches is that the former can only
mimic the natural target structures, whereas the latter
can potentially be used to expand into new structures,
i.e., the dark matter of protein-structure space.53,54
There are potential downsides from evolutionary bias in the
consensus approach55; indeed, it may even be hard to distin-
guish designed from natural sequences. Nonetheless, it has
worked well for the design of miniproteins and repeat pro-
teins, which can then be used as scaffolds for displaying resi-
dues that confer function such as binding.4,56 Pioneers of this
approach include: Jeremy Berg57,58; Barbara Imperiali,59
Zheng-yu Peng51,60; Andreas Plückthun,56,61 and Regan,4,62
with notable contributions from Ashley Buckle,63 Martin
Lehmann,64 Philippe Minard,65,66 and Oliver Rackham.67
Computational protein design5,7,68 generates and
evaluates full atomistic models for many different
sequences for a given design target in silico ahead of
experimental studies. The backbones can be fixed or
flexible, and can be generated by direct user input, fragment-
based approaches or parametrically. Side chains are then
added using algorithms that explore and test different rota-
meric states. The resulting atomistic models are scored using
relatively simplified forcefields or heuristics that relate
sequence, structure and internal energy. Therefore, the suc-
cess of these approaches depends on generating good start-
ing models for the backbone, rapid but reliable methods for
adding side chains, and the ability of the forcefields and
assessment methods to capture the salient features of pro-
tein stability and function. However, none of these are fool-
proof. Therefore, and increasingly, computational design is
used to guide the design of relatively small sequence libraries
of genes (usually hundreds to thousands), which can be
made by DNA synthesis, and then expressed and screened
or selected from to deliver stable or functional designs. Early
pioneers of computational protein design include: Alber38
with Pehr Harbury and Kim,69 DeGrado70; Tracey Handel,71
and Steve Mayo.68,72 The recent rise of computational design
has largely been due to Baker’s group and the development
of Rosetta.5,12,73 The approach is being adopted widely by
Baker, his former co-workers and others alike.74,75 Other
computational protein design platforms include OSPREY
from Bruce Donald,76,77 and ISAMBARD from Chris Wood,
Drew Thomson and my own lab.78
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N.B. In their excellent retrospective of de novo
protein design, Ivan Korendovych and DeGrado
give a more-detailed and fascinating review of the
field from its inception to current-day successes,
challenges and promise.7 They plot a helpful time-
line of the development of the field and its key mile-
stones. This is different but complementary to the
structure-based timeline that I present here. They
also define three eras of protein design that broadly
overlap with my own definitions: what I call minimal
protein design, they refer to as manual protein
design; where I use rational protein design, they
use computational design guided by fundamental
physicochemical principles, which is perhaps where
our definitions differ the most; and what I call com-
putational protein design, they expand to
fragment-based and bioinformatically informed
computational protein design.
Third, we should ask ourselves a tough question:
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Figure 1. A structural timeline for de novo protein design. The timeline is based on the year of publication of
primary papers that cite high-resolution de novo designed peptide and protein structures determined by X-ray
crystallography, NMR spectroscopy or, in a small number of cases, by cryo-electron microscopy (e.g. 6HQE,83
6M6Z,84 and 6WL185). The structures are represented by their 4-letter codes from the RCSB PBD (https://www.rcsb.
org/).20. The design categories—minimal (yellow), rational (red), consensus (*), and computational (blue)—are
defined in Box 1. In addition, in black, a number of structures of “engineered” peptides and proteins have been
included, as they have had an impact on de novo design, or are landmarks in the space between protein engineering
and design. These are for the GCN4 leucine zipper (2ZTA86); trimeric and tetrameric variants of the leucine zipper
(1GCL87); an engineered b-sheet miniprotein (1IC988) the Trp-Cage (1L2Y89); a trimmed-down miniprotein with
esterase activity (1V1D90); a selected combinatorial protein (2BH891); a selected ATP binding protein (2P0X92); a
cage complex computationally designed from natural proteins (3VCD93); a protein engineered using a reduced amino-
acid alphabet (3Q7W94); a computationally engineered uranyl-binding protein (4FZP95); a zinc-binding assembly
evolved to rapidly catalyse ester hydrolysis (5OD115) from a computationally designed de novo metal-binding dimer
MID1 (3VDE96); and an engineered variant of a foregoing computational design with a different topology (6G6H97).
Key: *, consensus design; +, one of multiple, related structures from the same publication; and underlined,
membrane-spanning designs. The list was compiled by manual inspection of the PDB using a combination of keyword
and author searches, and knowledge of the field. As such, it is somewhat subjective and may not be complete.
D.N. Woolfson Journal of Molecular Biology xxx (xxxx) xxxfunctions and our success in engineering these,
why design synthetic proteins at all? In the early
minimalist days of de novo protein design, the aim
was simply to test and develop our understanding
of sequence-to-structure relationships in proteins
by building albeit simple proteins from scratch. In
other words, it was a test of our understanding of
what Tom Creighton called the informational
aspect of the protein-folding problem.79 This fitted
Richard Feynman’s challenge, “What I cannot cre-
ate, I do not understand”. With some notable excep-
tions,80–82 the idea of making synthetic proteins that
might be functional or useful was far from designers’
minds. I am sure that this contributed to scepticism
of the emerging field by other protein scientists,
which protein designers perceived in the 1980s
and 1990s.7 Indeed, early on, the approaches were
largely minimal with relatively straightforward con-
cepts being tested; for example, the pioneering
work from the DeGrado and the Hecht groups
established the role of patterning of hydrophobic4
and polar residues (hp patterns) to define
secondary, tertiary and quaternary structures.3,23
Minimal design is still pursued with some success
and it has its place,6 but the design landscape has
changed radically. The field moved to rational and
computational design approaches, which I will focus
on for the remainder of this perspective. To bring
this full circle, I believe that advances here are
now putting us in a strong position to answer that
tricky question of why design synthetic proteins at
all? However, for de novo protein design to be
established as a parallel to protein engineering,
let alone as an alternative to it, hurdles remain in
the continued development of the field.A brief history of protein design through
structures
Before I move onto the main body of this
perspective, I will describe its two main figures.
These come with a caution: They are a structural
D.N. Woolfson Journal of Molecular Biology xxx (xxxx) xxxviewpoint of protein design over the past three
decades. Thus, they are biased to designs that
have been amenable to high-resolution X-ray
protein crystallography, NMR spectroscopy or,
more recently, cryo-electron microscopy; and they
overlook a large number of excellent designs that
are thoroughly characterised in solution, but which
have not been resolved to atomic resolution.
Andreas Plückthun once put it to me that the field
is obsessed with RMSD and we need to get on
with designing for function, if we want to be
relevant. By this he meant that the community has
been concerned mostly with the RMSD (root
mean squared deviation) between computational
models and experimental structures, and that
there are other tests of design success. For
instance, how good is a design’s function—e.g.,
for binding or catalysis—compared with natural
proteins? Notwithstanding this view, I find the
structural history a useful framework to discuss
the evolution of the field.
N.B. Baker and colleagues have produced their
own snapshot of structurally resolved
computational protein designs, which I refer
readers to.5
Figure 1 gives a timeline with the 4-letter RCSB
PDB codes for de novo protein designs that have
been determined to atomic resolution by X-ray
protein crystallography, NMR spectroscopy, or
cryo-electron microscopy.20 To illustrate points that
I make below, I call out these 4-letter codes fre-
quently in the text. Readers can view some of these
in Figure 2 and the others by typing the codes into
the search field of the URL, https://www.rcsb.org/.
This gallery of structures was culled by hand
through a series of author-name plus keyword
searches and knowledge of the field, and then sifted
by manual inspection. This was necessary
because, at present, there is no reliable automated
way to search for de novo protein designs in the
PDB. Therefore, Figure 1 is somewhat subjective
and most likely incomplete. Nonetheless, there
are several take-home messages from it.
First, the number high-resolution structures of de
novo designed peptides and proteins is increasing
exponentially: roughly, this doubled from the
1990s to the 2000s, and tripled from the 2000s to
the 2010s. For comparison, the whole PDB is
doubling in size approximately every 6–7 years.
There are now over 100 structures of de novo
peptides and proteins, which is a good resource
for the aforementioned bioinformatic analyses.
Second, the plot shows a transition in approaches
taken to protein design: The early minimal and
engineering approaches (coloured dark yellow and
black) have given way to rational design (red) and
increasing to computational design (blue). Third,
grouped within rational design, there was a
particularly successful push in consensus
design—defined in Box 1, and marked with *s in
Figures 1 and 2—during the 2000s led by5
Plückthun, Regan and others52,56. Fourth, in terms
of structures determined over the last decade,
rational and computational design appear to be on
a par; though the expectation is that the balance will
continue to shift towards computational design.
Finally, in both approaches, studies are increasingly
being supported by multiple high-resolution struc-
tures (marked ‘+’ in Figure 1), which probably
reflects both the increased accessibility of structure
determination and a raising of the bar in de novo
protein design.
Figure 2 shows ribbon diagrams for
representative examples of these structures.
Although I have attempted to cover as much of
the protein-design landscape as possible, this is
not meant to be a definitive collection of structures
achieved to date. I do hope that will follow. The
first thing to notice is that the early designs are
relatively short polypeptides with simple
structures. A rough metric to guesstimate the
length of a designed sequence from these
cartoons is that a turn of a helix spans 3.5
residues. Thus, with the exception of alpha3D
(2A3D98), the structures from the 1990s are for pep-
tides of 30 amino acids. This was for understand-
able reasons: most of these designs were
generated through minimal, rational, or very early
computational design, and realised experimentally
via solid-phase peptide synthesis. In the 2000s,
the growing ambitions of designers, increasing
computer power, accessibility of recombinant DNA
technology, and falling costs of synthetic DNA, all
contributed to the increased complexity of design
targets shown by the cartoons. This is particularly
apparent from 2015 onwards where the lengths
and complexities of structurally resolved de novo
proteins increasingly mirror those of natural
proteins.
A second observation from Figure 2 is that—like
JBS Haldane’s quip that “[God] has a special
preference for beetles”—protein designers have a
fondness for a helices. This makes sense too: The
a helix was an established model for protein-
folding studies by Buzz Baldwin and others in the
1980s and 1990s.112 This led to good sequence-
to-structure relationships and chemical principles
for building with this secondary structure. Moreover,
it is ‘self-contained’ with backbone hydrogen-
bonding potential satisfied internally, unlike b
strands that must do this by assembling and often
aggregating into b sheets.113,114 Thus, with the a
helix, designers can focus on using side-chain inter-
actions to drive the folding of tertiary structures and/
or the assembly of quaternary structures. This
emphasis on helical assemblies is changing with
advanced computational designs from the Baker
group for instance, leading to structures of both
water-soluble (6CZH115) and membrane-spanning
(6X9Z109) b-structured proteins. Further on
a-helical assemblies, however, it is interesting to
compare those achieved through rational and com-
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and curved a helices, which reflect those found in
natural globular and fibrillar proteins; whereas,
some of the computational designs use longer and
straighter helices (see 4TQL116 and 6B85107 for
example). Finally, as with natural proteins, there
are many fewer structures determined of de novo
membrane-spanning proteins (shaded boxes in Fig-
ure 2) than there are for water-soluble proteins.
Thus, the perennial challenge of working with natu-
ral transmembrane proteins extends into the design
space.6,80,84,107,108,110Evolution in protein design: From
minimal to rational approaches
As stated above, de novo protein design
necessarily began with minimal approaches.2,3,7,23
Mostly, these involved encoding synthetic polypep-
tides with patterns of hydrophobic (h) and polar (p)
residues spaced to match the helical periodicities
of the two main secondary structure types: i.e., vari-
ants of hpphppp with hydrophobic side chains
placed 3 and 4 residues apart to best match the
3.6 residues per turn of the a helix; and hphp pat-
terns with hydrophobic side chains every other resi-
due to match the 2 residues per turn of the b strand.
Often, this also employed reduced amino-acid pal-
ettes, with leucine as the favoured hydrophobic resi-
due, and lysine and glutamic acid the favoured polar
residues. The aim was for these sequences to fold
into amphipathic secondary structures that would
assemble in water driven by the hydrophobic effect
to form tertiary and quaternary structures.
Despite this simplicity, some of these studies led
to resolved protein structures, labelled yellow in
Figures 1 and 2. Some of these structures were
different from what was originally intended. For
example, DeGrado’s alpha1 peptide was
conceived to form a 4-helix bundle,3 but the X-ray
crystal structure indicated that a hexamer was also
accessible (1AL1117); and Hodges’ early a-helical
coiled-coil design targeting a parallel dimer29 was
adapted by DeGrado and Karyn O’Neill118 and later
shown to form a mixed parallel/antiparallel trimer
(1COS42). There is a long-standing and important
debate over the definitions and degrees of success
and failure in de novo protein design,119 and, as the3
Figure 2. A gallery of high-resolution de novo design
selected and representative structures from the structural ti
the 4-letter codes carry over from Figure 1. Structures are
(https://pymol.org/2/). Mostly, these are coloured “chainbow
Some images—mostly, for parallel homomeric helical as
additional protein chains are shown in grey these are for p
protein-protein interactions (4OYD,100 5VID,101 6IWB,102 6X
transmembrane structures (2MUZ,106 6B85,107 6MCT,108 6
hand corner of a box indicates that the de novo designe
characteristic of coiled-coil structures using the program SO
7
adages go, we may well learn more from the latter.
Indeed, these early approaches taught us some
important lessons. Not least, that simple chemico-
physical principles can be abstracted from natural
proteins and used as rules to deliver albeit rudimen-
tary protein-like structures. For me, the most impor-
tant lesson to emerge from this approach or era7
was the concept of negative protein design. In pos-
itive protein design, principles and rules are used to
design towards a target structure. But the shortcom-
ings of some of these early designs made the com-
munity realise that there was also the need to
design away from alternate states that lie close in
energy to the target state. As we will see, this con-
cept is as important today as it was 30 years ago.
The change towards modern protein design
occurred in the 1990s when people began to use
evolutionary and empirically derived information to
relate protein sequences and structures better and
beyond simple hp patterns. I see this as a natural
transition rather than as a step-change in the field.
Before that, the complexity of protein sequences
and structures, and the implications that this had
for solving the protein-folding problem were all too
apparent. For example, in protein-structure
prediction the great hope was that computational
approaches such as homology modelling,
threading, or fragment-based structure prediction
would crack that problem. That is, rather than a
series of rules or heuristics for folding protein
chains, a more-global view employing advanced
computational algorithms would be needed. This
has evolved from using amino-acid profiles or
position specific scoring matrices,120–122 through
fragment-based assembly,123 and onto advanced-
statistical or machine-learning methods.124 In turn,
this has led to good pipelines for homology mod-
elling,125 and the AI-based protein-fold predictions
epitomised by AlphaFold124 and its success in
CASP (Critical Assessment of methods for protein
Structure Prediction).126,127 Returning to protein
design, better understanding of sequence-to-
structure relationships was essential to deliver bet-
ter rules for protein design and to advance the field.
This spawned rational de novo protein design in the
1990s.
Relatively straightforward miniproteins like zinc
fingers and leucine zippers provided inspiration ined peptide and protein structures. The gallery shows
meline of Figure 1. The dates and colouring scheme for
represented as backbone cartoons rendered in PyMol
”, i.e. blue to red from the N terminus to the C terminus.
semblies—are coloured solid green for clarity. Where
rotein fusions to the designs (6FES99) or with targeted
XV,103 7JZL,104 6YWC105). Grey-shaded boxes indicate
M6Z,84 6X9Z,109 and 6YB1110). CC in the bottom right-
d structure tests positive for knobs-into-holes packing
CKET.111
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structure relationships and early design targets. In
natural examples, small numbers of key residues
act as keystones that largely determine the target
protein structures. For example, the critical
residues in one class of zinc fingers include 4-
residue combinations of Cys and His residues that
bind the zinc ion. Metal binding dictates the overall
fold of the protein, which is stabilised further by
the formation of a small hydrophobic core centred
on key hydrophobic and usually aromatic
residues.128,129 Moving into design, using a consen-
sus approach Berg and co-workers designed DNA-
binding zinc-finger proteins (1MEY58).57,130 There
were also early and successful attempts to replace
the zinc with an expanded hydrophobic core using
both consensus and computational design, notably
from Imperiali (1HCW*59) and Mayo (1FSD72),
respectively.
More broadly, and seeded by early successes
such as the Trp zipper (1LE0131) and the Trp cage
(1L2Y89), various stably folded de novominiproteins
have been successfully targeted: through rational
design from our lab (5LO2132); and via the computa-
tional design of constrained peptide (2ND2133) and
combined computational and selection studies
(5UOI134) from the Baker lab. Indeed today,
miniprotein design and, broader still, Sam Gell-
man’s foldamer concept135 are research fields in
themselves with considerable potential to deliver
bioactive functional peptides.136Coiled-coil assemblies as a special
and particularly accessible case
The rational approach to protein design and
engineering has led to a high level of
understanding for one class of protein structure in
particular; namely, the a-helical coiled coils.137,138
In these structures, amphipathic a helices are usu-
ally encoded by ‘heptad’ sequence repeats of
hydrophobic (h) and polar (p) residues, (hpphppp)3-
5. Two or more such helices combine through their
hydrophobic faces to form rope-like bundles. More-
over, the side-chain packing—which is key to suc-
cess in protein design—is intimate and highly
defined through so-called knobs-into-holes (KIH)
interactions.111,139 In the late 1980s and early
1990s, the aforementioned leucine zipper
(2ZTA86) provided the archetypal example of coiled
coils, and many researchers have used it as model
for experimental and computational studies of pro-
tein folding, engineering and design. Chief amongst
the proponents were Kim and, his collaborator, the
late and much-missed Tom Alber.69,86,87 As part of
their programme, Harbury showed that different oli-
gomers of leucine zipper could be made simply by
altering the two h positions of the coiled-coil heptad
repeat to different combinations of leucine and iso-
leucine (1GCL and 1GCM87). I do view this as step-8
change in the field, as it showed that subtly different
sequence repeats direct different core packings that
result in different quaternary structures. Moreover,
for the first time, these differences could be fully
understood to deliver clear sequence-to-structure
relationships for peptide assembly and rules for
rational peptide design.
Over the following two decades, more rules
emerged, making coiled coils probably the best
understood of peptide assemblies and protein
folds.36 In turn, this has led to considerable success
in the de novo design of coiled coils.35,37,140 To high-
light this, in Figure 2 I have labelled with ‘CC’ those
de novo designed structures that test positive for
KIH packing. Some of these mimic natural struc-
tures, which are mostly dimers, trimers and tetra-
mers: 1COS,42 1RH4,69 1BB1,38,39 1G6U,141
1U0I,43 6FES,99 and 6Q5S142; see also the ration-
ally designed coiled-coil basis set of homomeric
coiled coils from our group (4DZM and 4DZL143
and 3RA4144). Others are entirely new higher-
order barrel-like structures with accessible central
channels that can be functionalised, embedded in
membranes, or made to switch state: 3R3K,144
4PN8 and 4PNA,145 4UOT,116 5EHB,146 5EZC,14
6EIZ,147 6B85,107 6G67,97 6MCT,108 6YB1,110 and
6ZT1.148 N.B. Some of these examples—4PN8
and 4PNA,145 4UOT,116 5EHB,146 6FES,99
6B85107—are computational designs, which will be
described below.
Because of this progress in rational and
computational coiled-coil design, Korendovych
and DeGrado view it as a solved problem.7 I agree
in two respects: First, we understand the basic phy-
sics of coiled-coil assembly sufficiently to allow the
construction of accurate and realistic in silico mod-
els for any coiled-coil assembly. Indeed, there are
a number of web-based tools that make such mod-
elling accessible to all users.70,149–151 Second, the
basic chemistry, that is, the sequence-to-structure
relationships or rules for coiled-coil design are lar-
gely complete.7,35,37,97,142,152 However, in two other
respects I would disagree: First, we do not under-
stand the deeper chemical physics of coiled-coil
stability enough to determine and compare internal
energies in silico, let alone to calculate free energies
of assembly,DGassembly, for different design targets.
This will require a better and quantitative under-
standing of the non-covalent interactions that sta-
bilise folded proteins, and for these to be
incorporated into more-sophisticated computational
forcefields. Second, we do not understand the bio-
chemical subtleties of either natural or synthetic
coiled-coil assemblies; i.e., their dynamics and
any conformational changes that they undergo,
and how these impact on function153,154 or can be
exploited in design. That said, de novo coiled coils
that switch state are being designed and increas-
ingly being resolved to high resolution, see:
5EHB,146 6MSQ,155 6Q5S,142 7JH5,156 and
6ZT1.148 I will expand on both the current under-
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bly and design in another perspective elsewhere.
Before closing this subsection, it would be remiss
of me not to mention that coiled coils and 4-helix
bundles are proving to be superb scaffolds for
introducing metal-based functionality into de novo
scaffolds. I will not review this broad, detailed and
growing field here and refer you to excellent
reviews by others. This area has been pioneered
by DeGrado,7 Angela Lombardi,157 Pecoraro and
others, and is being advanced by them and others
such as Anderson,17 Brian Kuhlman and Hil-
vert,15,96 Anna Peacock.158
Revolution in protein design: The
emergence and establishment of
computational approaches
Computational approaches played a key role in
the development of rational protein design. For
example, although Harbury’s breakthrough
relating coiled-coil sequence repeats to quaternary
structures was experimental it was founded on
computational work began for his PhD thesis.87 Fur-
thermore, the rules that emerged from this work
were confirmed through computational analysis of
large numbers of natural sequences,159,160 and
have been used as the cornerstones of coiled-coil
design since.35,37 Moreover, consensus protein
design52,56 is essentially based in computational
bioinformatics with the design rules emanating from
multiple-sequence alignments of the targeted struc-
ture (Box 1). Although these applications of comput-
ers played a key role in shifting from back-of-the-
envelope (or in biro) designs, neither would be
called computational protein design as we know it
today.
As defined in Box 1, computational protein design
refers to the process of setting up an in silicomodel
of a target backbone structure and finding protein
sequences that are compatible with it. Such
approaches started to emerge in the 1990s with
the realisations that: not all targets would be
accessible through rational design; more-general
design methods would be needed; and protein
sequence and structural space is massive. My
personal view is that this resonated with themes in
protein engineering at the time, which were
moving from making specific point mutations,
through saturation mutagenesis, and into selecting
‘winners’ (i.e., stable or functional variants) from
either targeted or randomly generated mutant
libraries of natural proteins.161,162 In short, a move
to in silico screening of large protein libraries simply
made sense. The question was: how should this
best be done?
Exploring and assessing impossibly large
sequence and structural spaces: Broadly
speaking, in the early days of computational
protein design the problem was broken down into
three steps: first design or choose a backbone;9
second, superimpose on this many side-chain
combinations both in terms of sequences and
conformations; and third, assess which
combinations best fit the target. The assumption
was that the best fits would stabilise the targeted
fold when made experimentally. Thus, this was
very much a process of positive design. The early
approaches naturally focused on core-directed
design; i.e., finding combinations of hydrophobic
side chains that best filled the 3D void bounded by
the target backbone.68,162,163 Mayo’s contributions
are particularly noteworthy here—see 1FSD.164
Handel, Harbury and others also contributed to
the development of these approaches.69,71 To help
solve the problems of sorting through many residue
combinations and the impossibly large numbers of
associated side-chain conformations, Bassil
Dahiyat and Mayo applied branch-pruning or
dead-end-elimination algorithms.165 In regions, or
branches, of design space where side-chain confor-
mations were modelled to be incompatible with the
target—for instance, where a particular residue at a
specific position would always clash with the back-
bone—would be eliminated, or pruned, early in the
searches as they would contribute unfavourable
energies to any model. Since then, the building
and optimisation of core packing through guided
searches has been a key aspect of computational
protein design.12,116,145,166
Allowing more backbone variety and flexibility:
Early in computational design, it was apparent that
using fixed or natural backbones would be limiting,
and that the notion that backbones wouldn’t relax
or shift was naı̈ve. Some protein tertiary and
quaternary structures, such as the coiled coils and
repetitive helical or solenoid protein designs can
be described by a small number of geometric
parameters.36,167 In turn, parametric models for
such targets can be set up to explore a swathe of
tertiary and quaternary structures systematically.
This has led to several successful parametric-
design or partially parametric-design approaches.
The first of these was Harbury’s right-handed
coiled-coil tetramer, which also incorporates non-
proteinogenic side chains, 1RH4.69 As noted above,
the all-atom parametric modelling and design of
coiled-coil structures has now advanced to a point
where it is extremely robust, reliably and accessi-
ble,70,78,116,145,151,168 and even considered a largely
solved problem.7 The confidence that coiled-coil
backbones at least can be considered as defined,
allows the computational design process to focus
on other aspects of the problem. For example, the
heterotrimeric coiled coil 1BB139 was achieved by
optimising electrostatic interactions between differ-
ent patterns of charged side chains in three chains
chosen from > 2.7 million combinations of 256 pos-
sible sequences.38
More recent examples of what might be generally
considered parametric designs have tackled: a-
helical bundles, 4TQL,116 a-helical barrels,
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solenoids, 5CWB170 and 4GMR171; and an a/b
TIM-like barrel, 5BVL.172 Ideally to solve the back-
bone aspect of the protein-design problem, all pro-
tein structures would be described parametrically.
Generally, however, this is not possible—for exam-
ple, see the all-b-structured 6CZH115—and other
methods for generating backbones are needed.
Baker’s fragment-based design approach, which
was initially developed to address the protein-
folding problem and the CASP challenge,173 was
another clear landmark in computational protein
design. This has developed into the Rosetta suite
of computational modelling and design tools and is
being applied widely, successfully and impressively
by Baker’s own group, former group members, and
others.12,74,75 The first fragment-based design was
Kuhlman and Baker’s TOP7 design in 2003 –
1QYS.73 In essence, the targeted backbone is
pieced together from fragments from known protein
structures deposited in the PDB.20 Though there is
potential for generating de novo proteins with simi-
larity or homology to natural proteins, there is no
doubt that this has had a huge impact on the field
of computational de novo protein design and the
problem of generating initial backbones. Since then,
and through generalised frameworks such as
RosettaRemodel,174 fragment-based design has
developed into one of the most successful
approaches in de novo computational protein
design. These developments are described expertly
by recent reviews from Baker and DeGrado, so I will
not dwell on them here.5,7 The general approach
has also inspired or otherwise spawned a range of
approaches for backbone generation, including:
TERMS (tertiary structural motifs) from Gevorg
Grigoryan,175 and its application to the design of
de novo peptide-protein interactions with Amy Keat-
ing176; SEWING from Kuhlman and co-workers,
which combines pieces of natural protein struc-
tures, e.g. 2N8I;177 loop-helix-loop unit combinato-
rial sampling, or LUCS, from Kortemme’s group,
e.g. 6VGA;178 and TopoBuilder from Bruno Correia
and colleagues for incorporating functional ele-
ments into de novo protein frameworks.103,105
Gaps and remaining challenges: These advances
in computational de novo protein design are
allowing increasingly challenging design targets to
be addressed such as structures rich in b
structure – 2KL8,179 3WW7,180 5BVL,172 and
5KPE181; and membrane-spanning peptide and
protein assemblies – 2MUZ,106 6B85,107 6MCT,108
6M6Z,84 6X9Z,109 and 6YB1.110 In addition, and
particularly in the last half-decade, emphasis has
moved to functional protein design. For instance,
designer de novo peptides and proteins that bind
natural proteins of interest are being realised –
4OYD,100 5VID,101 6IWB,102 6XXV,103 7JH5,156
7JZL,104 and 6YWC.105 Also, with easy access to
some on-line computational design tools,151,182 the
field is opening up to non-specialist users and10designers – 6MRR.183 Nonetheless, considerable
challenges remain for computational design to
tackle, and indeed for protein design in general.
For example, it is increasingly appreciated that
computational protein design is not completely
robust, and often has to be used in combination
with experimental methods to deliver the goods. In
other words, many of the current computational
design methods get you so far, but then the
experimental cavalry is needed. One example of
this is in delivering stably folded structures –
5UOI,134 and 6XXV.103 In these examples, compu-
tational protein design delivers a library of potential
designs, genes for these are then made by parallel
DNA synthesis, and stable variants are selected via
yeast surface display and protease selection. Inter-
estingly, protease-based selection was envisaged
and demonstrated at the aforementioned conflu-
ence of the protein-engineering and protein-design
fields.184–187 It may be that such alliances between
computational and experimental approaches will
suffice to deliver robust and useful designs. How-
ever, there is a clear need to improve design rules,
computational methods, and particularly the force-
fields used to direct the in silico design process
and assess the designs. These would advance
computational protein design further to predict
whether a de novo protein will be stably folded or
not before it is made and characterised
experimentally.
Related to this, achieving small-molecule binding
and catalysis comparable to that observed in nature
using completely de novo designed scaffolds is an
ongoing and difficult challenge for the field. Again,
experimental screening and selection from
computationally directed libraries will likely
continue to be used profitably.8 However, improving
forcefields even further to capture more accurately
the weak non-covalent forces that drive and dis-
criminate protein-metal, protein-protein and
protein-small molecule interactions will be critical
for delivering better and more widely applicable
computational protein design. Nonetheless, pro-
gress is being made in the recognition and tight
binding of small molecules by de novo peptides
and proteins – 5TGY,188 6CZH,115 6EIZ,147 and
6W70.189 In addition, catalytic activities, with in
some cases very impressive catalytic efficiencies,
are being achieved by porting catalytic triads and
metals into completely de novo frameworks,17,190
with structures being resolved for some of these –
5EZC,14 5UGK,191 and 5OD1.15
Aligned with improving binding and catalysis by
de novo proteins, there is the challenge of
incorporating dynamics and conformational
changes in protein design. Nature evolves
proteins to be thermodynamically stable up to
thresholds set by the prevailing conditions; there
is no pressure for her to do anything more.
Indeed, there are clear advantages of limiting
protein stability, not least the ability to turnover
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their purpose. By contrast, protein designers have
always prided themselves on being able to
achieve hyperstable proteins.33,116,145,188 This
might help raise the thermodynamic bar of what is
possible in folding polypeptide chains to equal or
surpass that set by proteins from thermophiles.192
However, it may bring with it problems for functional
design. For in-cell applications, the aforementioned
protein turnover will be required. More generally, it
is well established that dynamics, conformational
changes, switching and allostery—which may be
hampered by hyperstability—are all critical for natu-
ral protein functions and regulation. This has always
been on the mind of protein designers,40,47,193–197
and, as noted above, structural transitions are being
incorporated into coiled-coil designs – 5EHB,146
6MSQ,155 6Q5S,142 7JH5,156 6ZT1,148 and.198 Gen-
eral approaches to this multistate design problem
are being developed and tested, though currently
on natural systems. For example, Roberto Chica
is developing dynamic and native conformational
exchangers (DANCERS)199; Patrick Barth is engi-
neering allosteric microswitches into transmem-
brane receptors200; and Sophie Barbe and
Thomas Schiex are using advanced computing for
positive multistate protein design.201 I anticipate
that these early examples and developing methods
will help make inroads in the design of synthetic pro-
teins to increasingly match the sophistication and
wonder of natural proteins.Conclusion
In summary, the past three decades have
witnessed considerable and impressive growth
and development of de novo protein design. The
field has moved on from largely empirical and
minimalist approaches that test our basic
understanding of protein folding, through rational
approaches that develop and apply sequence-to-
structure relationships or rules for protein design,
and onto computational protein design, which is
delivering complex protein structures and
functions. Along with this, more de novo protein
structures are being resolved to high resolution
(see Figures 1 and 2) and, increasingly, these
match the design models and functional
expectations. This has delivered > 100 structures
that can be fed back into the design-build-test-
learn cycle to improve protein design methods and
outcomes in future. That’s progress, and the
future for de novo protein design looks very bright
indeed.
Nonetheless, and as I have started to outline
above, there are challenges ahead. These include
the provision of better parametric, fragment-
based, and other methods to generate the initial
backbones for de novo design. These would allow
the further exploration of the dark matter of protein11space,53,54 and for de novo proteins to be built
around targeted functions rather than grafting func-
tions onto pre-existing scaffolds.18,105 Also, whilst
there is a growing number of de novo proteins that
bind small molecules and/or catalyse chemical
reactions, the routine and accurate design of speci-
fic and tight binding, and of catalysis remains chal-
lenging. Related to these functional targets, our
understanding of protein dynamics and conforma-
tional changes and our ability to capture these in
de novo proteins remains rudimentary. All of these
challenges must be addressed if we are to claim
that de novo protein design has come of age,5
and that it can operate alongside protein engineer-
ing. Most likely, this will require both advances in
computational designmethods—for instance, incor-
porating machine learning202 and virtual reality—
and improving our fundamental understanding of
the chemical physics of protein structure and func-
tion to deliver better forcefields for guiding and
assessing protein designs.5,12,203
Finally, given the progress on and power of
computational protein design, we should ask what
is the value of continuing with other approaches;
namely, minimal and rational design. My view is
that the case for pursuing purely minimal design is
increasingly difficult to make. Though, respected
colleagues of mine do present clear arguments for
continuing this for specific targets,6,204,205 and it
has the advantage of throwing up interesting sur-
prises where targeted rational and computational
approaches may not. The case for continuing
rational design is more balanced, which I illustrate
with recent examples from the design of a-helical
barrels. These are reasonably rare in nature,206
and engineering and design routes into this space
have been discovered serendipitously144,207 –
3R3K. Following this, de novo a-helical barrels have
been achieved through computational designs by
the Baker lab and my own group116,145 – 4PN8,
4PNA and 4UOT. Subsequent rational and empiri-
cal experimental studies of these have shown that
these are not all robust, with point or permutants
to both sets causing topological rearrangements
or even complete collapse of the structures –
6G6F and 6G6H.97 Consequently, the empirical
work has led to more-robust design rules not appar-
ent from the computational designs. In turn, these
design principles and examples of water-soluble
a-helical barrels have been used to tackle the
more-challenging problem of specifying helix-helix
interactions in membranes by DeGrado
(6MCT108), and to design membrane-spanning
ion-channel proteins and peptides from the Baker
lab (6M6Z107) and our group (6YB1110). In this vein,
I hope and anticipate that the rational rules-based
and powerful computational approaches to design
can be combined further and more widely to
achieve better de novo protein designs. By better I
mean that we can understand and rationalise the
designs delivered, and that we can use them for
D.N. Woolfson Journal of Molecular Biology xxx (xxxx) xxxapplications in biotechnology, medicine and syn-
thetic biology. Encouragingly, this is already hap-
pening with, for example, protein-design methods
being applied in biosensing.147,208–210
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